Rapidly involuting congenital haemangioma

Schafer, Fabiola; Tapia, M; Pinto, Cristian

doi:10.1136/archdischild-2013-304885

Search citation statements

Order By: Relevance

Paper Sections

Select...

Vascular Tumours1

Answers To the Questions On Page1

Vascular Tumors Congenital Hemangioma Benign Hemangioendot1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, such CHs do not express GLUT‐1 . Their further classification is largely based on the clinical history, as non‐involuting CH (NICH) or RICH, which may show histological differences at later stages .…”

Section: Vascular Tumoursmentioning

confidence: 99%

Phosphoinositide 3-kinase: a new kid on the block in vascular anomalies

2016

View full text Add to dashboard Cite

Section: Vascular Tumoursmentioning

confidence: 99%

Phosphoinositide 3-kinase: a new kid on the block in vascular anomalies

2016

View full text Add to dashboard Cite

“…Embolisation and laser can be considered for complications, including ulceration, bleeding and cardiac failure. If the lesion persists surgical resection may be required 5. Propranolol (beta-blocker) can be considered in infantile haemangiomas with their proliferative phase but is not routinely advised for congenital haemangiomas 2…”

Section: Answers To the Questions On Pagementioning

confidence: 99%

Neonate with a large neck mass

Thompson,

Kidd,

Winckworth

2024

Arch Dis Child Educ Pract Ed

View full text Add to dashboard Cite

“…Large RICH lesions may have a dramatic presentation at birth with high output heart failure (Figure 14B). Rapid involution is usually completed by 14 months of age 69,70,71 . Usually, RICH is managed conservatively, although complications based on size and location may prompt surgical excision.…”

Section: Vascular Tumors Congenital Hemangioma Benign Hemangioendotmentioning

confidence: 99%

Fetal brain, head, and neck tumors: Prenatal imaging and management

2020

View full text Add to dashboard Cite

Fetal tumors represent an infrequent pathology when compared to congenital malformations, although their true incidence may be underestimated. A variety of benign and malignant neoplasms may occur anywhere in the neural axis. Imaging plays an important role in the fetal tumor diagnosis and evaluation of their resultant complications. Discovery of a fetal mass on obstetric ultrasound necessitates further evaluation with prenatal magnetic resonance imaging (MRI). New MR sequences and new applications of existing techniques have been successfully implemented in prenatal imaging. A detailed assessment may be performed using a variety of MR. Fetal tumors may be histologically benign or malignant, but their prognosis generally remains poor, especially for intracranial lesions. Unfavorable tumor location or heightened metabolic demands on a developing fetus may result in severe complications and a fatal outcome, even in cases of benign lesions. Nowadays, prenatal treatment focuses mainly on alleviation of secondary complications caused by the tumors. In this article we review congenital tumors of the brain, face, and neck encountered in prenatal life, and discuss diagnostic clues for appropriate diagnosis.

show abstract

Rapidly involuting congenital haemangioma

Cited by 5 publications

References 3 publications

Phosphoinositide 3-kinase: a new kid on the block in vascular anomalies

Phosphoinositide 3-kinase: a new kid on the block in vascular anomalies

Neonate with a large neck mass

Fetal brain, head, and neck tumors: Prenatal imaging and management

Contact Info

Product

Resources

About